Results
|
1.
|
|
|
2.
|
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. MedStar authors:
Year: 2021
Citation: - Nature Medicine. 27(10):1818-1824, 2021 10.
Department: - MedStar Heart and Vascular Institute
Medline publication type:
All authors: - Axelsson A, Bach RG, Becker JR, Benson L, Braunwald , Bundgaard H, Burns KM, Canter C, Cirino AL, Colan SD, Day SM, Ho CY, Lakdawala NK, Lever HM, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Patel AR, Pereira AC, Rossano JW, Russell MW, Seidman CE, Solomon SD, Soslow JH, Taylor MRG, Thrush P, VANISH Investigators, Vargas JD, Wheeler MT, Wilmot I, Zahka K
|
|
3.
|
Cardiac care for older adults. Time for a new paradigm. MedStar authors:
Year: 2011
Citation: - Journal of the American College of Cardiology. 57(18):1801-10, 2011 May 3.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alexander KP, Cleveland JC Jr, Forman DE, Krumholz HM, Maurer MS, Najjar SS, Rich MW, Wenger NK, Zieman S
|
|
4.
|
Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. MedStar authors:
Citation: - Science Translational Medicine. 5(215):215re3, 2013 Dec 11.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bottomley PA, Gerstenblith G, Hirsch GA, Lai S, Najjar SS, Panjrath GS, Steinberg A, Weiss RG, Wu K
|
|
5.
|
Developing New Treatments for Heart Failure: Focus on the Heart. MedStar authors:
Year: 2016
Citation: - Circulation: Heart Failure. 9(5), 2016 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Butler J, Carr J, Cleland JG, Colucci WS, Crandall D, Deckelbaum LI, Dinh W, Dunnmon P, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Krahn T, Kramer F, Larson CJ, Okada S, Parsey RV, Sabbah HN, Senni M, Shah SJ, Sikora S, Stockbridge N, Wahlander K
|
|
6.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|